Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function-Reference-Cited by-同舟云学术

Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function

Published:2001-01 Issue:1 Volume:51 Page:45-50
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Di Mauro Maurizio,Papalia G,Le Moli R,Nativo B,Nicoletti F,Lunetta M

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference28 articles.

1. Growth hormone levels in severe renal failure;Samaan;Metabolism,1970

2. Growth hormone in uremia. Plasma growth hormone, insulin and glucagon after oral and intravenous glucose in uraemic subjects;Ørskov;Scand. J. Clin Lab. Invest.,1971

3. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action;Bauer;Life Sci.,1982

4. Somatostatin analog SMS 201–995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas;Serrano-Rios;J. Clin. Endocrinol. Metabol.,1986

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Directed differentiation of pancreatic δ cells from human pluripotent stem cells;Nature Communications;2024-07-27

2. Application of urine C-peptide creatinine ratio in type 2 diabetic patients with different levels of renal function;Frontiers in Endocrinology;2022-11-17

3. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease;Cochrane Database of Systematic Reviews;2018-09-24

4. Effects of anti-somatostatin agents on glucose metabolism;Diabetes & Metabolism;2017-10

5. Diabète induit par les somatostatinergiques;Médecine des Maladies Métaboliques;2016-12